Dako Signs Another CDx Deal with Amgen | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dako said on Monday that it has entered into an additional collaboration with Amgen to develop a companion diagnostic for an Amgen cancer drug candidate.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.